247 related articles for article (PubMed ID: 33512451)
1. Linking the KIR phenotype with STAT3 and TET2 mutations to identify chronic lymphoproliferative disorders of NK cells.
Pastoret C; Desmots F; Drillet G; Le Gallou S; Boulland ML; Thannberger A; Doncker AV; Salaun V; Damaj GL; Veyrat-Masson R; Tournilhac O; Moignet A; Pangault C; Roussel M; Fest T; Lamy T
Blood; 2021 Jun; 137(23):3237-3250. PubMed ID: 33512451
[TBL] [Abstract][Full Text] [Related]
2. Frequent somatic TET2 mutations in chronic NK-LGL leukemia with distinct patterns of cytopenias.
Olson TL; Cheon H; Xing JC; Olson KC; Paila U; Hamele CE; Neelamraju Y; Shemo BC; Schmachtenberg M; Sundararaman SK; Toro MF; Keller CA; Farber EA; Onengut-Gumuscu S; Garrett-Bakelman FE; Hardison RC; Feith DJ; Ratan A; Loughran TP
Blood; 2021 Aug; 138(8):662-673. PubMed ID: 33786584
[TBL] [Abstract][Full Text] [Related]
3. STAT3 mutations in natural killer cells are associated with cytopenia in patients with chronic lymphoproliferative disorder of natural killer cells.
Kawakami T; Sekiguchi N; Kobayashi J; Yamane T; Nishina S; Sakai H; Hirabayashi Y; Nakazawa H; Ishida F
Int J Hematol; 2019 May; 109(5):563-571. PubMed ID: 30859397
[TBL] [Abstract][Full Text] [Related]
4. A high definition picture of somatic mutations in chronic lymphoproliferative disorder of natural killer cells.
Gasparini VR; Binatti A; Coppe A; Teramo A; Vicenzetto C; Calabretto G; Barilà G; Barizza A; Giussani E; Facco M; Mustjoki S; Semenzato G; Zambello R; Bortoluzzi S
Blood Cancer J; 2020 Apr; 10(4):42. PubMed ID: 32321919
[TBL] [Abstract][Full Text] [Related]
5. Somatic mutations in
Gao LM; Zhao S; Zhang WY; Wang M; Li HF; Lizaso A; Liu WP
Cancer Biol Ther; 2019; 20(10):1319-1327. PubMed ID: 31311407
[TBL] [Abstract][Full Text] [Related]
6. Tracing the roots of CLPD-NK by TET2 and STAT3.
Herling M; Braun T
Blood; 2021 Jun; 137(23):3156-3158. PubMed ID: 34110400
[No Abstract] [Full Text] [Related]
7. STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia.
Jerez A; Clemente MJ; Makishima H; Koskela H; Leblanc F; Peng Ng K; Olson T; Przychodzen B; Afable M; Gomez-Segui I; Guinta K; Durkin L; Hsi ED; McGraw K; Zhang D; Wlodarski MW; Porkka K; Sekeres MA; List A; Mustjoki S; Loughran TP; Maciejewski JP
Blood; 2012 Oct; 120(15):3048-57. PubMed ID: 22859607
[TBL] [Abstract][Full Text] [Related]
8. Myelodysplastic Syndrome associated TET2 mutations affect NK cell function and genome methylation.
Boy M; Bisio V; Zhao LP; Guidez F; Schell B; Lereclus E; Henry G; Villemonteix J; Rodrigues-Lima F; Gagne K; Retiere C; Larcher L; Kim R; Clappier E; Sebert M; Mekinian A; Fain O; Caignard A; Espeli M; Balabanian K; Toubert A; Fenaux P; Ades L; Dulphy N
Nat Commun; 2023 Feb; 14(1):588. PubMed ID: 36737440
[TBL] [Abstract][Full Text] [Related]
9. Genomic landscape of T-large granular lymphocyte leukemia and chronic lymphoproliferative disorder of NK cells: a single institution experience.
Fei F; Stehr H; Zehnder JL
Leuk Lymphoma; 2023 Sep; 64(9):1536-1544. PubMed ID: 37330635
[TBL] [Abstract][Full Text] [Related]
10. Ascorbic Acid Promotes
Wu CY; Zhang B; Kim H; Anderson SK; Miller JS; Cichocki F
J Immunol; 2020 Sep; 205(6):1513-1523. PubMed ID: 32759296
[TBL] [Abstract][Full Text] [Related]
11. STAT3 gene mutations and their association with pure red cell aplasia in large granular lymphocyte leukemia.
Ishida F; Matsuda K; Sekiguchi N; Makishima H; Taira C; Momose K; Nishina S; Senoo N; Sakai H; Ito T; Kwong YL
Cancer Sci; 2014 Mar; 105(3):342-6. PubMed ID: 24350896
[TBL] [Abstract][Full Text] [Related]
12. The utility of flow cytometry in differentiating NK/T cell lymphoma from indolent and reactive NK cell proliferations.
de Mel S; Li JB; Abid MB; Tang T; Tay HM; Ting WC; Poon LM; Chung TH; Mow B; Tso A; Ong KH; Chng WJ; Liu TC
Cytometry B Clin Cytom; 2018 Jan; 94(1):159-168. PubMed ID: 28431200
[TBL] [Abstract][Full Text] [Related]
13. T cell large granular lymphocyte leukemia and chronic NK lymphocytosis.
Barilà G; Calabretto G; Teramo A; Vicenzetto C; Gasparini VR; Semenzato G; Zambello R
Best Pract Res Clin Haematol; 2019 Sep; 32(3):207-216. PubMed ID: 31585621
[TBL] [Abstract][Full Text] [Related]
14. Chronic lymphoproliferative disorder of NK-cells: A single-institution review with emphasis on relative utility of multimodality diagnostic tools.
Kurt H; Jorgensen JL; Amin HM; Patel KP; Wang SA; Lin P; Kanagal-Shamanna R; Loghavi S; Thakral B; Khogeer HA; Jabbour EJ; Li S; Yin CC; Medeiros LJ; Khoury JD
Eur J Haematol; 2018 May; 100(5):444-454. PubMed ID: 29385279
[TBL] [Abstract][Full Text] [Related]
15. Detection of monoclonal T populations in patients with KIR-restricted chronic lymphoproliferative disorder of NK cells.
Gattazzo C; Teramo A; Passeri F; De March E; Carraro S; Trimarco V; Frezzato F; Berno T; Barilà G; Martini V; Piazza F; Trentin L; Facco M; Semenzato G; Zambello R
Haematologica; 2014 Dec; 99(12):1826-33. PubMed ID: 25193965
[TBL] [Abstract][Full Text] [Related]
16. Expression of killer cell inhibitory receptors is restricted to true NK cell lymphomas and a subset of intestinal enteropathy-type T cell lymphomas with a cytotoxic phenotype.
Dukers DF; Vermeer MH; Jaspars LH; Sander CA; Flaig MJ; Vos W; Willemze R; Meijer CJ
J Clin Pathol; 2001 Mar; 54(3):224-8. PubMed ID: 11253136
[TBL] [Abstract][Full Text] [Related]
17. Genomic landscape of TCRαβ and TCRγδ T-large granular lymphocyte leukemia.
Cheon H; Xing JC; Moosic KB; Ung J; Chan VW; Chung DS; Toro MF; Elghawy O; Wang JS; Hamele CE; Hardison RC; Olson TL; Tan SF; Feith DJ; Ratan A; Loughran TP
Blood; 2022 May; 139(20):3058-3072. PubMed ID: 35015834
[TBL] [Abstract][Full Text] [Related]
18.
Muñoz-García N; Jara-Acevedo M; Caldas C; Bárcena P; López A; Puig N; Alcoceba M; Fernández P; Villamor N; Flores-Montero JA; Gómez K; Lemes MA; Hernández JC; Álvarez-Twose I; Guerra JL; González M; Orfao A; Almeida J
Cancers (Basel); 2020 Nov; 12(12):. PubMed ID: 33255665
[No Abstract] [Full Text] [Related]
19. Phenotypic profile of expanded NK cells in chronic lymphoproliferative disorders: a surrogate marker for NK-cell clonality.
Bárcena P; Jara-Acevedo M; Tabernero MD; López A; Sánchez ML; García-Montero AC; Muñoz-García N; Vidriales MB; Paiva A; Lecrevisse Q; Lima M; Langerak AW; Böttcher S; van Dongen JJ; Orfao A; Almeida J
Oncotarget; 2015 Dec; 6(40):42938-51. PubMed ID: 26556869
[TBL] [Abstract][Full Text] [Related]
20. Co-infection of Cytomegalovirus and Epstein-Barr Virus Diminishes the Frequency of CD56
Lam JKP; Azzi T; Hui KF; Wong AMG; McHugh D; Caduff N; Chan KH; Münz C; Chiang AKS
Front Immunol; 2020; 11():1231. PubMed ID: 32625211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
